Taken together, these data do not support broadly applicable epigenetic priming in NSCLC.

Here, we report that epigenetic priming of enhancers signifies developmental competence during endodermal lineage diversification.

Here we describe a series of investigations testing whether epigenetic priming with azacitidine and entinostat increases sensitivity of NSCLC to cytotoxic agents.